1. Home
  2. QFIN vs ALKS Comparison

QFIN vs ALKS Comparison

Compare QFIN & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QFIN
  • ALKS
  • Stock Information
  • Founded
  • QFIN 2016
  • ALKS 1987
  • Country
  • QFIN China
  • ALKS Ireland
  • Employees
  • QFIN N/A
  • ALKS N/A
  • Industry
  • QFIN Finance: Consumer Services
  • ALKS Biotechnology: Pharmaceutical Preparations
  • Sector
  • QFIN Finance
  • ALKS Health Care
  • Exchange
  • QFIN Nasdaq
  • ALKS Nasdaq
  • Market Cap
  • QFIN 5.3B
  • ALKS 4.4B
  • IPO Year
  • QFIN 2018
  • ALKS 1991
  • Fundamental
  • Price
  • QFIN $30.74
  • ALKS $28.17
  • Analyst Decision
  • QFIN Strong Buy
  • ALKS Buy
  • Analyst Count
  • QFIN 1
  • ALKS 12
  • Target Price
  • QFIN $23.80
  • ALKS $35.42
  • AVG Volume (30 Days)
  • QFIN 1.3M
  • ALKS 1.9M
  • Earning Date
  • QFIN 11-19-2024
  • ALKS 10-24-2024
  • Dividend Yield
  • QFIN 3.84%
  • ALKS N/A
  • EPS Growth
  • QFIN 25.79
  • ALKS 55.25
  • EPS
  • QFIN 4.12
  • ALKS 1.97
  • Revenue
  • QFIN $2,351,728,381.00
  • ALKS $1,505,121,000.00
  • Revenue This Year
  • QFIN $4.15
  • ALKS N/A
  • Revenue Next Year
  • QFIN $4.39
  • ALKS N/A
  • P/E Ratio
  • QFIN $7.45
  • ALKS $12.33
  • Revenue Growth
  • QFIN 9.80
  • ALKS N/A
  • 52 Week Low
  • QFIN $13.71
  • ALKS $22.22
  • 52 Week High
  • QFIN $35.23
  • ALKS $32.88
  • Technical
  • Relative Strength Index (RSI)
  • QFIN 46.04
  • ALKS 49.75
  • Support Level
  • QFIN $29.15
  • ALKS $28.10
  • Resistance Level
  • QFIN $32.65
  • ALKS $30.30
  • Average True Range (ATR)
  • QFIN 1.05
  • ALKS 0.84
  • MACD
  • QFIN -0.57
  • ALKS 0.11
  • Stochastic Oscillator
  • QFIN 26.15
  • ALKS 50.32

About QFIN Qifu Technology Inc.

Qifu Technology Inc is a Credit-Tech platform in China. It provides credit services more accessible and personalized to consumers and SMEs through Credit-Tech services to financial institutions, whereby it deploys its technology solutions to help financial institutions identify the diversified needs of consumers and SMEs, effectively access prospective borrowers that are creditworthy through multi-channels, enhance credit assessment on prospective borrowers, and manage credit risks and improve collection strategies and efficiency, among others.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: